Inflammatory CNS demyelination: Histopathologic correlation with in vivo quantitative proton MR spectroscopy

American Journal of Neuroradiology

Volumn 20, Issue 9, 1999, Pages 1619-1627

  Bitsch, Andreas ^b   Bruhn, Harald ^b   Vougioukas, Vassilios ^b   Stringaris, Argyris ^b   Lassmann, Hans ^b   Frahm, Jens ^b   Brück, Wolfgang ^a  

^a Institut fur Neuropathologie   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATORY DISEASE; MALE; MULTIPLE SCLEROSIS; NEURORADIOLOGY; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ASPARTIC ACID; AXONS; BIOPSY, NEEDLE; BLOOD-BRAIN BARRIER; BRAIN; CELL DIVISION; CHOLINE; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; DOMINANCE, CEREBRAL; FEMALE; GLIOSIS; HUMANS; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MULTIPLE SCLEROSIS; NEUROGLIA;

EID: 0032706872     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Lassmann H. Comparative Neuropalhology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis. Berlin, Heidelberg: Springer-Verlag; 1983
2. Prineas J. W. The neuropathology of multiple sclerosis. In: Koetsier, J. C. Demyelinating Diseases. Amsterdam: Elsevier Science Publishers; 1985:8:213-257
3. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of Multiple Sclerosis pathology indicates heterogeneity in pathogcnesis. Brain Palhol 1996:6:259-274
4. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992;18:319-334
5. Miller DH, Grossman RI, Reingold SC, McFarland HE The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998:121:3-24
6. Brück W, Bitsch A, Kolenda H, Brück Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neural 1997;42:783-793
7. Arnold DL, Matthews PM, Francis G, Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the cvalu-ation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 1990;14:154-159
8. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995;! 18:1583-1592
9. De Stefano N, Matthews PM, Antel JP, Prcul M, Francis G, Arnold DL. Chemical pathology of acute demyclinating lesions and its correlation with disability, dun Neural 1995:38:901-909
10. Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Frahm J. Noninvasive assessment of brain lesions by fast scan MRI and localized proton spcctroscopy. Neuroradiotogy 1991;33:S279-S281
11. Bruhn H, Frahm J, Merboldt KD, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spcctroscopy in vivo .Ann Neural 1992-32:140-150
12. Arnold DL, Matthews PM, Francis GS, O'Connor J, Antel JP. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neural 1992;31:235-241
13. Koopmans RA, Li DKB, Zhu G, Allen PS, Penn A, Paty DW. Magnetic resonance spcctroscopy of multiple sclerosis: in-vivo detection of myclin breakdown products. Lancet 1993:341:631-632
14. Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of brain disorders in childhood. In: Bachelard, H. S. Magnetic Resonance Spectroscopy and Imaging in Neurochemistry. New York: Plenum Press 1997:12:329-402
15. Kim MO, Lee SA, Choi CG, Huh JR, Lee MC. Halo's concentric sclerosis: a clinical case study of brain MRI, biopsy, and proton magnetic resonance spectroscopic findings. J Neural Neurosurg Psych 1997;62:655-658
16. Silver NC, Barker RA, MacManus DG, et al. Proton magnetic resonance spcctroscopy in a pathologically confirmed acute demyelinating lesion. J Neural 1997:244:204-207
17. Davies SEC, Newcombe J, Williams SR, McDonald WI, Clark JB. High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochetn 1995:64:742-748
18. Poser S, Lüer W, Bruhn H, Frahm J, Brück Y, Felgenhauer K. Acute demyelinating disease. Classification and non-invasive diagnosis. Ada Neural Scand 1992;86:579-585
19. Brück W, Porada P, Poser S, et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neural 1995:38:788-796
20. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neural 1983:13:227-231
21. Brück W, Schmied M, Suchanek G, et al. Oligodendrocytcs in the early course of multiple sclerosis. Ann Neural I994;35:65-73
22. Colmait DR, Kreibich G, Frey AB, Sabatini DD. Synthesis and incorporation of myelin polypeptides into CNS myelin. J Cell Biol 1982:95:598-608
23. Breitschopf H, Suchanek G, Gould RM, Colman DR, Lassmann H. In situ hybridization with digoxigenin-labeled probes: sensitive and reliable detection method applied to myelinating rat brain. Acta Neiiropathol 1992;84:581-587
24. Mews I, Bergmann M, Bunkowski S, Gullotta F, Brück W. Oligodcndrocytc and axon pathology in clinically silent multiple sclerosis lesions. Multiple Sclerosis 1998;4:55-62
25. 1H-NMR spectroscopy of human brain. Water suppression, short echo times, and 1 mL resolution. J Magn Reson 1990;1990:464-473
26. Michaelis T, Merboldt K-D, Bruhn H, Hänicke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993; 187:219-227
27. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30:672-679
28. Pouwels PJW and Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998;39:53-60
29. Ferguson B, Matyszak MFC, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120:393-399
30. Trapp B D, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transcction in the lesions of multiple sclerosis. New Engl J Med 1998:338:278-285
31. De Stefano N, Matthews PM, Narayanan S, Francis GS, Antel JP, Arnold DL. Axonal dysfunction and disability in a relapse of multiple sclerosis: longitudinal study of a patient. Neurology 1997;49:1138-1141
32. Davie CA, Havvkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58
33. Urenjak J, Williams SR, Gadian DG, Noble M. Proton magnetic resonance spectroscopy unambigously identifies different neural cell types. J Neurosci 1993;13:981-989
34. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-l MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 1989;172:541-548
35. Jimenez JV, Richards TL, Heide AC, Grierson JR, Shankland EG. Incorporation of a phosphonium analogue of choline into the rat brain as measured by magnetic resonance spectroscopy. Magn Reson Med 1995;33:285-292
36. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized proton NMR spectroscopy in different regions of the human brain in vivo: relaxation times and concentrations of cerebral metabolites. Magn Reson Med 1989;11:47-63
37. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology 1991;41:1251-1256
38. Brenner RE, Munro PMG, Williams SCR.et al. The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737-745
39. 1H spectroscopic imaging. Ann Neural 1994;36:157-165
40. Matthews PM, Pioro E, Narayanan S, et al. Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 1996; 119:715-722
41. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:189-198
42. Landtblom A-M, Sjöqvist L, Söderfeldt B, Nyland H, Thuomas K-A. Proton MR spectroscopy and MR imaging in acute and chronic multiple sclerosis - ringlike appearances in acute plaques. Ada radial 1996;37:278-287
43. Pouwels PJW, Hanefeld F, Frahm J. Proton MRS in PelizaeusMerzbacher disease. Neuropediatrics 1997;23:355-356
44. Pan WP, Hetherington HP, Vaughan JT, Mitchell G, Pohost GM, Whitaker JN. Evaluation of multiple sclerosis by 'H spectroscopic imaging at 4.1 T. Magn Reson Med 1996;36:72-77
45. Lopez-Villegas D, Lenkinski RE, Wehrli SL, Ho W-Z, Douglas SD. Lactate production by human monocytes/macrophages determined by proton MR spectroscopy. Magn Reson Med 1995; 34:32-38